Yuchong Peng

1.0k total citations
38 papers, 730 citations indexed

About

Yuchong Peng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yuchong Peng has authored 38 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Yuchong Peng's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Ubiquitin and proteasome pathways (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Yuchong Peng is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Ubiquitin and proteasome pathways (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Yuchong Peng collaborates with scholars based in China, Brunei and Egypt. Yuchong Peng's co-authors include Linglong Yin, Youhong Liu, Bowen Yuan, Qianling Zhu, Tuoyu Cao, Yingxue Gao, Xiaohui Yu, Xuegong Fan, Liang Ma and Xiong Li and has published in prestigious journals such as PLoS ONE, Oncogene and British Journal of Cancer.

In The Last Decade

Yuchong Peng

37 papers receiving 723 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yuchong Peng 398 218 192 147 125 38 730
Shunli Shen 349 0.9× 187 0.9× 249 1.3× 179 1.2× 101 0.8× 32 689
Amanda Mikels‐Vigdal 254 0.6× 206 0.9× 174 0.9× 100 0.7× 109 0.9× 14 662
Chaohui Zuo 422 1.1× 169 0.8× 273 1.4× 128 0.9× 123 1.0× 45 823
Imane El Dika 207 0.5× 214 1.0× 145 0.8× 178 1.2× 69 0.6× 30 573
Haosheng Jin 420 1.1× 294 1.3× 342 1.8× 177 1.2× 106 0.8× 52 913
Yajin Chen 550 1.4× 235 1.1× 340 1.8× 195 1.3× 99 0.8× 43 959
Tameyoshi Yamamoto 253 0.6× 253 1.2× 199 1.0× 264 1.8× 116 0.9× 30 675
Guannan Tang 407 1.0× 170 0.8× 366 1.9× 80 0.5× 136 1.1× 23 726
Bei‐Ge Jiang 308 0.8× 135 0.6× 219 1.1× 111 0.8× 73 0.6× 27 650
Binsheng Fu 414 1.0× 254 1.2× 272 1.4× 173 1.2× 82 0.7× 49 874

Countries citing papers authored by Yuchong Peng

Since Specialization
Citations

This map shows the geographic impact of Yuchong Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuchong Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuchong Peng more than expected).

Fields of papers citing papers by Yuchong Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuchong Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuchong Peng. The network helps show where Yuchong Peng may publish in the future.

Co-authorship network of co-authors of Yuchong Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yuchong Peng. A scholar is included among the top collaborators of Yuchong Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuchong Peng. Yuchong Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Jing‐Xuan, Yuangang Su, Yuanyuan Chen, et al.. (2025). Immune infiltration landscape and potential drug-targeted implications for hepatocellular carcinoma with ‘progression/hyper-progression’ recurrence. Annals of Medicine. 57(1). 2456113–2456113. 2 indexed citations
2.
3.
Peng, Yuchong, Jingjing Huang, Youhong Liu, et al.. (2024). SKP2 inhibition activates tumor cell-intrinsic immunity by inducing DNA replication stress and genomic instability. British Journal of Cancer. 132(1). 81–92. 5 indexed citations
4.
Xu, Jing‐Xuan, Yuanyuan Chen, Lu‐Nan Qi, & Yuchong Peng. (2024). Investigation of the causal relationship between breast cancer and thyroid cancer: a set of two-sample bidirectional Mendelian randomization study. Endocrine. 87(1). 196–205. 1 indexed citations
5.
6.
Peng, Yuchong, Youhong Liu, Yubing Ye, et al.. (2023). PLK1 maintains DNA methylation and cell viability by regulating phosphorylation-dependent UHRF1 protein stability. Cell Death Discovery. 9(1). 367–367. 6 indexed citations
7.
Deng, Tanggang, Lin Xie, Zhenbin Zhang, et al.. (2023). ATM-Mediated translocation of RanBPM regulates DNA damage response by stabilizing p21 in non-small cell lung cancer cells. Cellular Oncology. 47(1). 245–258. 4 indexed citations
8.
Cao, Tuoyu, Yubing Ye, Youhong Liu, et al.. (2023). AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer. Oncogenesis. 12(1). 1–1. 15 indexed citations
9.
Peng, Yuchong, et al.. (2022). Gut microbiome dysbiosis in patients with hepatitis B virus-related hepatocellular carcinoma after extended hepatectomy liver failure. Annals of Translational Medicine. 10(10). 549–549. 10 indexed citations
10.
Peng, Yuchong, Jing‐Xuan Xu, Xinhua Zhao, et al.. (2022). Operable hepatitis B virus-related hepatocellular carcinoma: gut microbiota profile of patients at different ages. Annals of Translational Medicine. 10(8). 477–477. 4 indexed citations
11.
12.
Peng, Yuchong, et al.. (2019). A meta-analysis of MDR1 polymorphisms rs1128503 and rs1045642 and susceptibility to hepatocellular carcinoma. Journal of International Medical Research. 47(7). 2800–2809. 4 indexed citations
13.
14.
Peng, Yuchong, Youhong Liu, Yingxue Gao, et al.. (2019). USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis. Journal of Experimental & Clinical Cancer Research. 38(1). 468–468. 35 indexed citations
15.
Yin, Linglong, Youhong Liu, Yuchong Peng, et al.. (2018). PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells. Journal of Experimental & Clinical Cancer Research. 37(1). 153–153. 91 indexed citations
16.
Yu, Xiaohui, Youhong Liu, Linglong Yin, et al.. (2018). Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition. Oncogene. 38(4). 549–563. 46 indexed citations
17.
Yuan, Bowen, Youhong Liu, Xiaohui Yu, et al.. (2018). FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness. Cell Death and Disease. 9(5). 562–562. 41 indexed citations
18.
Zhu, Qianling, Zheng Li, Yongbo Peng, et al.. (2017). The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells. Cell Death and Disease. 8(3). e2659–e2659. 100 indexed citations
19.
Peng, Yuchong, Jian‐Hong Zhong, Zhibo Xie, et al.. (2016). Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activity. Tumor Biology. 37(8). 10943–10958. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shunli Shen Breakdown of academic impact, for papers by Amanda Mikels‐Vigdal Breakdown of academic impact, for papers by Chaohui Zuo Breakdown of academic impact, for papers by Imane El Dika Breakdown of academic impact, for papers by Haosheng Jin Breakdown of academic impact, for papers by Yajin Chen Breakdown of academic impact, for papers by Tameyoshi Yamamoto Breakdown of academic impact, for papers by Guannan Tang Breakdown of academic impact, for papers by Bei‐Ge Jiang Breakdown of academic impact, for papers by Binsheng Fu
Rankless by CCL
2026